07 November 2023

Safety update of pharmaceutical product “Erleada (Apalutamide)”

Reference: CIR-2023-00000198

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adherence to what is stated

 

Safety update of pharmaceutical product “Erleada (Apalutamide)”

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

اضافة تحذير على المنتج الطبي - Erleada ( Apalutamide) --.pdf:

View Document